Market Size in 2024 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 13.25 Billion | USD 26.48 Billion | 8.00% | 2023 |
The global polymerase chain reaction (PCR) market size was worth around USD 13.25 billion in 2023 and is predicted to grow to around USD 26.48 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.
The study includes drivers and restraints for the polymerase chain reaction market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the polymerase chain reaction market on a global level.
In order to give the users of this report a comprehensive view on the polymerase chain reaction market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market.
The study provides a decisive view on the polymerase chain reaction market by segmenting the market based on products, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2023 to 2032. Based on product, the market is segmented into instruments, reagents and consumables and software. Based on the end user, the market is segregated into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals and academic and research organization.
Report Attributes | Report Details |
---|---|
Report Name | Polymerase Chain Reaction (PCR) Market Research Report |
Market Size in 2024 | USD 13.25 Billion |
Market Forecast in 2032 | USD 26.48 Billion |
Growth Rate | CAGR of 8.00% |
Number of Pages | 215 |
Key Companies Covered | Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson & Company and Thermo Fischer Scientific. |
Segments Covered | By Product, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., U.K., Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for polymerase chain reaction market based on technology in all the regions and countries.
The global polymerase chain reaction (PCR) market is led by players like:
Global Polymerase Chain Reaction Market: Product Segment Analysis
Global Polymerase Chain Reaction Market: End-User Segment Analysis
Global Polymerase Chain Reaction Market: Regional Segment Analysis
FrequentlyAsked Questions
A prevalent molecular biology method, Polymerase Chain Reaction (PCR) enables the amplification of a particular DNA segment. Since its inception in 1983 by Kary Mullis, PCR has emerged as an indispensable instrument in a vast array of biological and biomedical contexts. The procedure entails enzymatic amplification of a specific segment of target DNA, which generates a substantial number of copies of that segment.
Market expansion can be stimulated by continuous developments in polymerase chain reaction (PCR) technologies, including the creation of innovative enzymes, enhanced reagents, and more effective thermal cyclers, which improve the performance and dependability of PCR assays. The expanding scientific applications of PCR, such as in the fields of genomics, transcriptomics, and epigenetics, contribute to the expansion of the market. PCR is an indispensable instrument in numerous molecular biology investigations.
The global polymerase chain reaction (PCR) market size was worth around USD 13.25 billion in 2023 and is predicted to grow to around USD 26.48 billion by 2032.
The global polymerase chain reaction (PCR) market with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.
Regional segmentation comprises present and projected demand for the following regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This is further subdivided into significant countries such as the United States, United Kingdom, Germany, France, China, Japan, India, Brazil, and others. This segmentation encompasses the technological demand for polymerase chain reaction across all regions and countries.
The report also includes detailed profiles of end players such as Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson & Company and Thermo Fischer Scientific.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed